Sign in
4

Changes in Ownership

ImmunityBio, Inc. Filed Acc 0001326110-22-000018

Options or other derivatives

  • CEO & President acquired 700,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Adcock Richard · CEO & President

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-03-23 Grant or award : show line 1 in the form Stock Option (right to buy) +350,000 350,000 D
2022-03-23 Grant or award : show line 2 in the form Stock Option (right to buy) +350,000 350,000 D
Loading xslF345X03/wf-form4_164825664654486.xml…